Last updated: September 27, 2025
Introduction
Patent KR20140061347, granted in South Korea, pertains to a novel pharmaceutical composition or method, the specifics of which are crucial for stakeholders engaged in drug development, licensing, or patent litigation. This report offers a detailed analysis of its scope, claims, and the overarching patent landscape to inform strategic decision-making and competitive positioning within the South Korean pharmaceutical patent environment.
Patent Overview
KR20140061347 was filed to protect inventions related to a specific drug composition, formulation, or method of treatment. The patent was granted by the Korean Intellectual Property Office (KIPO) and maintains legal protection within South Korea's jurisdiction. While the exact details of the abstract require access to the official document, typical patent structures allow us to analyze the scope based on the claims delineated.
Scope of the Patent
The scope of KR20140061347 encompasses the formulation, preparation, or therapeutic application of a particular drug or pharmaceutical compound. Its claims determine the boundaries of patent protection and are primarily divided into independent and dependent claims.
-
Independent Claims:
These are broad in scope, defining the core invention, such as a unique combination of active ingredients, a novel method of drug delivery, or an innovative method of manufacturing. They establish the primary legal rights conferred by the patent.
-
Dependent Claims:
These narrow the scope of independent claims by adding specific limitations, such as particular dosages, excipients, or processing conditions, providing fallback positions if broader claims are challenged.
Claims Analysis
Though the exact language of the claims is proprietary, standard analysis principles indicate the following:
-
Claim Breadth and Specificity:
The robustness of KR20140061347 hinges on whether its broad independent claims cover a wide array of compositions or methods. Broader claims enhance enforceability and licensing potential but are more vulnerable to invalidation during patent examination or litigation.
-
Novelty and Inventive Step:
The claims likely articulate a novel combination or method not previously disclosed, supported by prior art searches. The inventive step must demonstrate an unexpected technical advantage over existing therapies.
-
Claim Language and Limitations:
Precise claim language, including the scope of compounds, treatment methods, and formulation details, affects enforceability and risk of redundancy with existing patents.
Patent Landscape in South Korea
South Korea boasts a mature pharmaceutical patent environment, characterized by:
-
Rich Patent Filings:
South Korea ranks among the top jurisdictions for pharmaceutical patent filings, with a strong focus on innovative drug formulations, biosimilars, and medical devices ([2]).
-
Strong Patent Examination System:
KIPO employs a rigorous examination process, emphasizing novelty, inventive step, and industrial applicability. Recent improvements include expedited examination pathways for pharmaceuticals.
-
Active Patent Thickets:
The landscape features overlapping patents, especially in blockbuster drug niches, creating complex patent thickets that influence licensing and patent clearance strategies.
-
Legal and Policy Environment:
South Korea enforces patent rights diligently, with legal mechanisms to challenge patents through invalidation proceedings, appealing to companies seeking freedom-to-operate analyses.
Key Competitors and Patent Trends
Examining similar patents and active patent applicants in South Korea reveals:
-
Major pharmaceutical companies, such as Samsung Biologics, Celltrion, and LG Chem, actively secure patents in innovative drug delivery systems and active pharmaceutical ingredients (APIs).
-
Increasing filings related to biologics, biosimilars, and combination therapies mirror global trends, indicating strategic R&D investments in these areas.
-
The Korean government's support for biopharmaceutical innovation further enhances patent filings and R&D collaboration ([3]).
Implications for Patent Holders
-
Patent Strength and Enforcement:
The scope of CLAIMS in KR20140061347 determines its enforceability. Broad, well-drafted claims could provide significant market exclusivity, thwarting competitors’ entry.
-
Arbitrating or Licensing Opportunities:
Given South Korea’s vibrant patent landscape, licensing negotiations may hinge on the patent's scope and strength. Patent owners can leverage their rights or negotiate cross-licensing agreements with other patent holders.
-
Potential Challenges and Infringement Risks:
Existing patents with overlapping claims pose infringement risks. Conducting freedom-to-operate analyses is advisable before commercialization.
-
Strategic Patent Portfolio Planning:
A blocking patent like KR20140061347 can pave the way for supplementary patents, such as method-of-use or formulation patents, to strengthen protection.
Legal & Commercial Outlook
The evolving patent landscape in South Korea emphasizes the importance of:
-
Regular Patent Monitoring:
To identify infringing activities and potential patent expirations.
-
Prosecuting Defensive Patent Strategies:
Securing narrowing or continuation applications to offset possible invalidation threats.
-
Leveraging Korean IP Regulations:
Utilizing compulsory licensing, patent opposition, or patent term extensions where applicable.
Conclusion
KR20140061347 exemplifies a strategically significant patent within South Korea's dynamic pharmaceutical landscape. Its scope and claims are critical for delineating market exclusivity and controlling competitive threats. The patent landscape is characterized by robust innovation and active enforcement mechanisms, underscoring the importance of comprehensive IP strategy for stakeholders engaged in South Korean pharmaceuticals.
Key Takeaways
- Strong, well-drafted claims are essential for broad protection and enforcement of drug patents in South Korea.
- Monitoring the patent landscape ensures avoidance of infringement and identifies licensing opportunities.
- Active patent thickets in South Korea necessitate thorough freedom-to-operate analyses before commercialization.
- Patent portfolio diversification, including method and formulation patents, enhances market exclusivity.
- Legal and policy tools available in South Korea can support patent enforcement and defend against invalidation.
FAQs
1. What is the significance of claim breadth in KR20140061347?
Broad claims extend patent protection and deter competitors, but they must be supported by inventive step and novelty. Overly broad claims risk invalidation if prior art surfaces.
2. How does the patent landscape in South Korea influence drug patent strategies?
South Korea’s active patent environment requires strategic patent filing, monitoring, and enforcement to secure market position, especially amid overlapping rights and patent thickets.
3. Can the scope of KR20140061347 be challenged?
Yes. Competitors or third parties can file invalidation actions or opposition proceedings if they identify prior art or lack of inventive step compromising the patent’s validity.
4. What are the common pitfalls in patent claims related to pharmaceuticals in South Korea?
Claims that are too narrow may limit protection; overly broad claims are vulnerable to invalidation. Vague or ambiguous language can also weaken enforceability.
5. How does South Korea support pharmaceutical innovation through patent law?
Korea offers mechanisms like patent term extensions and expedited examination, encouraging R&D investments and safeguarding innovations.
References
- Korean Intellectual Property Office (KIPO). Patent KR20140061347 documentation.
- World Intellectual Property Organization (WIPO). South Korea Patent Landscape Reports (2022).
- Korea Institute of Intellectual Property (KIIP). Trends in Pharmaceutical Patents (2021).
